Unexpected structures formed by the kinase RET C634R mutant extracellular domain suggest potential oncogenic

Yixin Liu1, Orquidea De Castro Ribeiro1, Outi Haapanen2

  • 1Molecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.

Insights

The RET receptor tyrosine kinase

Area of Science:

  • Oncology
  • Molecular Biology
  • Structural Biology

Background:

  • The RET receptor tyrosine kinase is crucial for cell functions, and its dysregulation contributes to cancer development.
  • Mutations in the RET extracellular domain (ECD) are linked to Multiple Endocrine Neoplasia type 2A (MEN2A), a hereditary cancer syndrome.
  • Structural understanding of RET mutations in MEN2A remains limited.

Purpose of the Study:

  • To elucidate the structural consequences of the C634R mutation in the RET ECD, the most prevalent MEN2A mutation.
  • To investigate the impact of this mutation on RET dimerization and ligand binding.

Main Methods:

  • Electron microscopy was employed to determine the structure of the RET C634R mutant ECD.
  • Structural comparisons were made between the mutant and wild-type (WT) RET ECD in the presence and absence of ligands.

Main Results:

  • The C634R mutation induces ligand-independent dimerization of the RET ECD in an unusual tail-to-tail conformation.
  • This mutant dimer exhibits distinct structural characteristics compared to the ligand-induced dimer of WT RET.
  • The RET C634R ECD dimer forms novel complexes with RET ligands, differing structurally from WT RET-ligand complexes.

Conclusions:

  • The structural insights into the RET C634R mutant ECD reveal a potential mechanism for cancer induction in MEN2A, independent of ligand binding.
  • These findings suggest that altered RET ECD structure and dimerization are key drivers of MEN2A pathogenesis.
  • The study highlights potential therapeutic targets for intervening in RET-driven cancers.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.7K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
13.8K